Related Experiment Video
Updated: Aug 14, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Drug-induced expansion of infarct: morphologic and functional correlations
Abstract:
It has been established that glucocorticoids and several nonsteroidal antiinflammatory drugs, when administered early after coronary occlusion, interfere with myocardial scar formation. To determine whether this action is associated with expansion of myocardial infarct during the first week of coronary occlusion and whether expansion affects ventricular function, the effects of indomethacin on the left ventricle in the early phase of infarction were studied. In a blinded randomized study, experimental myocardial infarction was produced in 17 open-chest dogs by ligation of the proximal left anterior descending coronary artery; the treated group (n = 8) received 10 mg/kg iv indomethacin at 15 min and 3 hr after occlusion, and the control group (n = 9) received saline. After 7 days, regional function expressed as percent change of area (% delta A) of the left ventricular cavity was calculated from short-axis two-dimensional echocardiograms at the level of the infarct, the animals were killed, and their hearts were examined. The ratio of infarct thickness to noninfarcted wall thickness was 1.20 +/- 0.08 (mean +/- SEM) in the control group, and the ratio was lower in the indomethacin group, 0.96 +/- 0.04 (p less than .025). An expansion index of myocardial infarction was calculated as previously described and was 1.02 +/- 0.04 in the control group vs 1.29 +/- 0.06 in the indomethacin group (p less than .005). In eight dogs (six control and two treated) without expansion (expansion index less than 1.09), regional function expressed as % delta A was 46.8 +/- 2.6% (SEM), and in nine dogs (six treated and three control) with expansion, % delta A was significantly lower, 28.7 +/- 4.0% (p less than .005).(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Indomethacin treatment after coronary occlusion reduced myocardial infarct expansion and preserved left ventricular function in dogs. This finding highlights the impact of early anti-inflammatory drug intervention on cardiac remodeling and function post-infarction.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Cardiac Remodeling
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids can affect myocardial scar formation post-coronary occlusion.
- Early intervention may influence infarct expansion and subsequent ventricular function.
Purpose of the Study:
- To investigate the effect of indomethacin on left ventricular infarct expansion in the early phase after coronary occlusion.
- To determine if infarct expansion influences ventricular function.
Main Methods:
- A blinded, randomized study in 17 dogs with experimentally induced myocardial infarction.
- Treatment group received intravenous indomethacin; control group received saline.
- Echocardiography and post-mortem heart examination were used to assess infarct size, expansion, and regional function after 7 days.
Main Results:
- Indomethacin significantly reduced the ratio of infarct wall thickness to non-infarcted wall thickness (0.96 vs 1.20).
- Indomethacin treatment led to a higher expansion index (1.29 vs 1.02), indicating reduced infarct expansion.
- Dogs with infarct expansion showed significantly lower regional ventricular function (% delta A: 28.7% vs 46.8%).
Conclusions:
- Early administration of indomethacin interferes with myocardial infarct expansion.
- Reduced infarct expansion is associated with better preservation of regional left ventricular function.
- These findings suggest a potential therapeutic window for NSAIDs in managing early cardiac remodeling after myocardial infarction.

